NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF

Described herein are NOD-like receptor protein 3 (NLRP3) inflammasome inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with NLRP3 inflammasome pathway. L'invention conce...

Full description

Saved in:
Bibliographic Details
Main Authors LIU, Yingtao, DING, Xiaoyu, LI, Chaopeng, WU, Jianping, QIN, Luoheng
Format Patent
LanguageEnglish
French
Published 10.05.2024
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract Described herein are NOD-like receptor protein 3 (NLRP3) inflammasome inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with NLRP3 inflammasome pathway. L'invention concerne des inhibiteurs de l'inflammasome de la protéine 3 du récepteur de type NOD (NLRP3) et des compositions pharmaceutiques comprenant lesdits inhibiteurs. Les composés et les compositions de l'invention sont utiles dans le traitement d'une maladie ou d'un trouble associés à la voie de l'inflammasome NLRP3.
AbstractList Described herein are NOD-like receptor protein 3 (NLRP3) inflammasome inhibitors and pharmaceutical compositions comprising said inhibitors. The subject compounds and compositions are useful for the treatment of a disease or disorder associated with NLRP3 inflammasome pathway. L'invention concerne des inhibiteurs de l'inflammasome de la protéine 3 du récepteur de type NOD (NLRP3) et des compositions pharmaceutiques comprenant lesdits inhibiteurs. Les composés et les compositions de l'invention sont utiles dans le traitement d'une maladie ou d'un trouble associés à la voie de l'inflammasome NLRP3.
Author DING, Xiaoyu
QIN, Luoheng
LIU, Yingtao
WU, Jianping
LI, Chaopeng
Author_xml – fullname: LIU, Yingtao
– fullname: DING, Xiaoyu
– fullname: LI, Chaopeng
– fullname: WU, Jianping
– fullname: QIN, Luoheng
BookMark eNrjYmDJy89L5WTQ8_MJCjBW8PRz83H09XUM9vd1BXI8PJ08Q_yDghUc_VwUQoNdgxVCPFyDXP3deBhY0xJzilN5oTQ3g7Kba4izh25qQX58anFBYnJqXmpJfLi_kYGRiYGliaGpgaOhMXGqAHMrKFw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITEURS DE L'INFLAMMASOME NLRP3 ET LEURS UTILISATIONS
ExternalDocumentID WO2024094150A1
GroupedDBID EVB
ID FETCH-epo_espacenet_WO2024094150A13
IEDL.DBID EVB
IngestDate Fri Jul 19 10:43:30 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO2024094150A13
Notes Application Number: WO2023CN129502
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240510&DB=EPODOC&CC=WO&NR=2024094150A1
ParticipantIDs epo_espacenet_WO2024094150A1
PublicationCentury 2000
PublicationDate 20240510
PublicationDateYYYYMMDD 2024-05-10
PublicationDate_xml – month: 05
  year: 2024
  text: 20240510
  day: 10
PublicationDecade 2020
PublicationYear 2024
RelatedCompanies INSILICO MEDICINE IP LIMITED
RelatedCompanies_xml – name: INSILICO MEDICINE IP LIMITED
Score 3.5370033
Snippet Described herein are NOD-like receptor protein 3 (NLRP3) inflammasome inhibitors and pharmaceutical compositions comprising said inhibitors. The subject...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title NLRP3 INFLAMMASOME INHIBITORS AND USES THEREOF
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240510&DB=EPODOC&locale=&CC=WO&NR=2024094150A1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFfWmVfFRJaDkttqk28QciuRJIk02pKn2VppkBUHSYiP-fSfbVHvqbXcHZh_MzDezj1mA-6eBNtcMtSA6yhOhBe2RTMkzwtV3g1OOTsX6tkWk-RP6Mh1MW_C5eQsj8oT-iOSIqFE56nsl7PXyfxPLEXcrV4_ZBzYtnr106MhNdIzwhDImO9bQjZnDbNm2MW6To2RNMxCteibGSnvoSOu1PrivVv0uZbkNKt4x7MfIr6xOoMXLDhzam7_XOnAQNkfeWGy0b3UKD9EoiftSEHkjMwzNMQtdrPiBFaQsGUtm5EgTNI9S6ruJy7wzuPPc1PYJdjz7m-fsjW2Psn8O7XJR8guQ1KL-IUfTVYQcqszVjCvod1Cu5cXcUArlErq7OF3tJl_DUV0lIiVpF9rV1ze_QaStsluxQL94Zns2
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLamgRg3GCAGAyqBeiusXdfSw4T6SNVCX-o62G3qI0hIqJtYEX8fN-tgp92SWHIeiv3ZSewA3D2OlFTRpEJQcT8JciEPhEzMM4FK7xqVKRoV69cWgeJM5efZaNaCz00sDMsT-sOSI6JE5SjvFdPXy_9DLIu9rVw9ZB_YtHiyk7HFN94xwhPuMd4yxiQKrdDkTRP9Nj6I1zQN0Wqgo6-0h0a2WssDeTXquJTlNqjYR7AfIb-yOoYWLbvQMTd_r3XhwG-uvLHYSN_qBO4DL46GnBvYnu77-iT0CVYc13CTMJ5wemBxU1SPXOKQmIT2KdzaJDEdATue_81z_hZuj3J4Bu1yUdJz4KSi_iFHUSWEHFlMpYyKaHfIVMmLVBMLsQf9XZwudpNvoOMkvjf33ODlEg5rksDSk_ahXX190ytE3Sq7Zov1C2sXfik
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=NLRP3+INFLAMMASOME+INHIBITORS+AND+USES+THEREOF&rft.inventor=LIU%2C+Yingtao&rft.inventor=DING%2C+Xiaoyu&rft.inventor=LI%2C+Chaopeng&rft.inventor=WU%2C+Jianping&rft.inventor=QIN%2C+Luoheng&rft.date=2024-05-10&rft.externalDBID=A1&rft.externalDocID=WO2024094150A1